Neurology Central

Novel drug target identified for glioblastoma treatment

A group of researchers led by Masaharu Noda and Akihiro Fujikawa of the National Institute for Basic Biology (Okazaki, Japan) have recently demonstrated that the pharmacological inhibition of R5 receptor-type protein tyrosine phosphatases (RPTPs) by a small molecule, termed NAZ2329, could be a promising strategy for the treatment of malignant gliomas.
Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.